Ischemic stroke, the most common subtype of stroke, has been one of the leading causes of mobility and mortality worldwide.\nHowever, it is still lacking of efficient agents. Stem cell therapy, with its vigorous advantages, has attracted researchers around\nthe world. Numerous experimental researches in animal models of stroke have demonstrated the promising efficacy in treating\nischemic stroke. The underlying mechanism involved antiapoptosis, anti-inflammation, promotion of angiogenesis and\nneurogenesis, formation of new neural cells and neuronal circuitry, antioxidation, and blood-brain barrier (BBB) protection.\nThis review would focus on the types and neuroprotective actions of stem cells and its potential mechanisms for ischemic stroke.
Loading....